Cancer Immunotherapy Is Expected To Reach Us$ 310 Bn By Registering A Stupendous CAGR Of 10% By The End Of The Forecast Period 2023-2032
A recent report published by Fact.MR points towards disequilibrium in the distribution of cancer immunotherapy in developing and developed regions. In the U.S., high frequency …